Pfizer fined £84m for ‘excessive’ epilepsy drug pricing
The government’s competition watchdog has fined manufacturer Pfizer and distributor Flynn Pharma a total of nearly £90 million for overcharging the NHS for an anti-epilepsy drug.
The government’s competition watchdog has fined manufacturer Pfizer and distributor Flynn Pharma a total of nearly £90 million for overcharging the NHS for an anti-epilepsy drug.